
### [MONDO:0016118](http://purl.obolibrary.org/obo/MONDO_0016118)
**Label:** muscular glycogenosis

**Subclasses:** [MONDO:0010392](http://purl.obolibrary.org/obo/MONDO_0010392) (glycogen storage disease due to phosphoglycerate kinase 1 deficiency), [MONDO:0009293](http://purl.obolibrary.org/obo/MONDO_0009293) (glycogen storage disease V), [MONDO:0017699](http://purl.obolibrary.org/obo/MONDO_0017699) (glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form), [MONDO:0013046](http://purl.obolibrary.org/obo/MONDO_0013046) (glycogen storage disease due to muscle beta-enolase deficiency), [MONDO:0017698](http://purl.obolibrary.org/obo/MONDO_0017698) (glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form), [MONDO:0013047](http://purl.obolibrary.org/obo/MONDO_0013047) (glycogen storage disease due to lactate dehydrogenase M-subunit deficiency), [MONDO:0009295](http://purl.obolibrary.org/obo/MONDO_0009295) (glycogen storage disease VII), [MONDO:0017701](http://purl.obolibrary.org/obo/MONDO_0017701) (glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form), [MONDO:0018348](http://purl.obolibrary.org/obo/MONDO_0018348) (polyglucosan body myopathy type 1), [MONDO:0010281](http://purl.obolibrary.org/obo/MONDO_0010281) (Danon disease), [MONDO:0017700](http://purl.obolibrary.org/obo/MONDO_0017700) (glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form), [MONDO:0017695](http://purl.obolibrary.org/obo/MONDO_0017695) (glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form), [MONDO:0017694](http://purl.obolibrary.org/obo/MONDO_0017694) (glycogen storage disease due to acid maltase deficiency, infantile onset), [MONDO:0017697](http://purl.obolibrary.org/obo/MONDO_0017697) (glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form), [MONDO:0017696](http://purl.obolibrary.org/obo/MONDO_0017696) (glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form), [MONDO:0010362](http://purl.obolibrary.org/obo/MONDO_0010362) (glycogen storage disease IXd), [MONDO:0018485](http://purl.obolibrary.org/obo/MONDO_0018485) (glycogen storage disease due to acid maltase deficiency, late-onset), [MONDO:0013291](http://purl.obolibrary.org/obo/MONDO_0013291) (glycogen storage disease XV), [MONDO:0009897](http://purl.obolibrary.org/obo/MONDO_0009897) (adult polyglucosan body disease), [MONDO:0009865](http://purl.obolibrary.org/obo/MONDO_0009865) (glycogen storage disease due to phosphoglycerate mutase deficiency), [MONDO:0009868](http://purl.obolibrary.org/obo/MONDO_0009868) (glycogen storage disease IXb), [MONDO:0009290](http://purl.obolibrary.org/obo/MONDO_0009290) (glycogen storage disease II), [MONDO:0014526](http://purl.obolibrary.org/obo/MONDO_0014526) (polyglucosan body myopathy type 2), [MONDO:0009292](http://purl.obolibrary.org/obo/MONDO_0009292) (glycogen storage disease due to glycogen branching enzyme deficiency), 

**Corr. equiv. classes:** [OMIM:263570](http://purl.obolibrary.org/obo/OMIM_263570), [Orphanet:365](http://www.orpha.net/ORDO/Orphanet_365), [Orphanet:206583](http://www.orpha.net/ORDO/Orphanet_206583), [OMIM:261750](http://purl.obolibrary.org/obo/OMIM_261750), [Orphanet:308670](http://www.orpha.net/ORDO/Orphanet_308670), [Orphanet:308552](http://www.orpha.net/ORDO/Orphanet_308552), [Orphanet:263297](http://www.orpha.net/ORDO/Orphanet_263297), [OMIM:616199](http://purl.obolibrary.org/obo/OMIM_616199), [OMIM:261670](http://purl.obolibrary.org/obo/OMIM_261670), [Orphanet:308655](http://www.orpha.net/ORDO/Orphanet_308655), [Orphanet:308698](http://www.orpha.net/ORDO/Orphanet_308698), [Orphanet:308712](http://www.orpha.net/ORDO/Orphanet_308712), [Orphanet:420429](http://www.orpha.net/ORDO/Orphanet_420429), [Orphanet:308638](http://www.orpha.net/ORDO/Orphanet_308638), [Orphanet:99849](http://www.orpha.net/ORDO/Orphanet_99849), [Orphanet:713](http://www.orpha.net/ORDO/Orphanet_713), [OMIM:612932](http://purl.obolibrary.org/obo/OMIM_612932), [Orphanet:34587](http://www.orpha.net/ORDO/Orphanet_34587), [Orphanet:715](http://www.orpha.net/ORDO/Orphanet_715), [OMIM:612933](http://purl.obolibrary.org/obo/OMIM_612933), [OMIM:613507](http://purl.obolibrary.org/obo/OMIM_613507), [Orphanet:371](http://www.orpha.net/ORDO/Orphanet_371), [Orphanet:284426](http://www.orpha.net/ORDO/Orphanet_284426), [OMIM:300653](http://purl.obolibrary.org/obo/OMIM_300653), [OMIM:300257](http://purl.obolibrary.org/obo/OMIM_300257), [Orphanet:308684](http://www.orpha.net/ORDO/Orphanet_308684), [OMIM:300559](http://purl.obolibrary.org/obo/OMIM_300559), [Orphanet:456369](http://www.orpha.net/ORDO/Orphanet_456369), [Orphanet:308621](http://www.orpha.net/ORDO/Orphanet_308621), [OMIM:232300](http://purl.obolibrary.org/obo/OMIM_232300), [OMIM:232800](http://purl.obolibrary.org/obo/OMIM_232800), [OMIM:232500](http://purl.obolibrary.org/obo/OMIM_232500), [OMIM:232600](http://purl.obolibrary.org/obo/OMIM_232600), [Orphanet:79240](http://www.orpha.net/ORDO/Orphanet_79240), [Orphanet:97234](http://www.orpha.net/ORDO/Orphanet_97234), [Orphanet:368](http://www.orpha.net/ORDO/Orphanet_368), [Orphanet:367](http://www.orpha.net/ORDO/Orphanet_367), [Orphanet:397937](http://www.orpha.net/ORDO/Orphanet_397937), 

**Class expressions from DL-Learner:**

- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 30.31%
- [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 29.41%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 28.60%
- Thing 28.59%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 28.59%
- [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 24.89%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 23.46%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) 23.39%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 20.52%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 19.49%
- [HP:0000079](http://purl.obolibrary.org/obo/HP_0000079) (Abnormality of the urinary system) 16.84%
- [HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system) 16.20%
- [HP:0000007](http://purl.obolibrary.org/obo/HP_0000007) (Autosomal recessive inheritance) 16.18%
- [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 15.49%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 15.31%


